6550--DNA Extraction Reagents Minneapolis VA Health Care System
Veterans Affairs · NETWORK CONTRACT OFFICE 23 (36C263)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26326R0054 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
DNA Extraction Reagents supply for Minneapolis VA Health Care System. This is a solicitation conducted using FAR Part 12 (Acquisition of Commercial Products and Commercial Services). Solicitation number 36C26326R0054 is issued as a request for quotes (RFQ). This is a full and open competition solicitation. Prospective offerors must be registered and current in the System for Award Management (SAM) database at time of offer to the Government (https://www.sam.gov). For SDVOSB vendors offerors must be registered at SBA Small Business Search at https://search.certifications.sba.gov/ as a SDVOSB Qu… (show all)
otes will only be accepted from responsible contractors. The NAICS code for the solicitation is 325413 with a size standard of 1,250 Employees. A list of the contract line items, quantities, and units of measure are listed within the RFQ solicitation documentation to follow. The VA anticipates one Firm Fixed Price award to provide supplies to the Minneapolis VA Health Care System, Minneapolis MN 55417. The period of performance is 6-1-2026 to 9-30-2026 for the base year period of performance. Technical questions on this solicitation are due via e-mail only to Robert Bennett, Contract Specialist, at robert.bennett8@va.gov no later than 4:00 PM on 5/6/2026. Quotes are due at the Contracting Office by 4:00 pm on 5/13/2026. Quotes are required to be emailed to robert.bennett8@va.gov prior to the solicitation closing date and time. It is the responsibility of the offeror to ensure their quote is received in its entirety by the Contracting Officer before the solicitation closing.
Who won similar work
6 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 23 (36C263)), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (6): middle half $268K to $431K, median $325K; range $82K to $771K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| MICROGENICS CORPORATION · $TMO · $46.3B | 2 | $852K | Jan 10, 2025 |
| BIOMERIEUX INC | 2 | $650K | Oct 1, 2026 |
| GRIFOLS DIAGNOSTIC SOLUTIONS INC. | 1 | $452K | Oct 21, 2025 |
| Roche Diagnostics Minneapolis MN 55417 USA | 1 | $263K | Jun 21, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $46.3B revenue (12 months to Jun 27, 2026). The median single-winner award in these 6 past awards, $325K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026BIOMERIEUX INC$284K6550--DO Biofire Panel Kits in support of the Sioux Falls VA HCSNo listed company matched (Materiality N/A)
- Jun 21, 2026Roche Diagnostics Minneapolis MN 55417 USA$263K6550--(IHC) Staining System - MPLSNo listed company matched (Materiality N/A)
- Oct 21, 2025GRIFOLS DIAGNOSTIC SOLUTIONS INC.$452K6550--MPLS - Blood Bank Automation System - GrifolsNo listed company matched (Materiality N/A)
- Apr 24, 2025BIOMERIEUX INC$366KBlood Culture Testing Equipment and ServicesNo listed company matched (Materiality N/A)
- Jan 10, 2025MICROGENICS CORPORATION$82K6550--MPLS - Microgenics DRI Ecstasy Plus Assay Reagents Supply Contract Award NoticeMateriality: <0.01% of $TMO revenue (Low) SEC
- Dec 5, 2024MICROGENICS CORPORATION$771K6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for AssaysMateriality: <0.01% of $TMO revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (7 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $40K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 7 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.